|
Arnie’s Rebounding World: My Answer Came Too Soon
The Myeloma Beacon Arnie’s Rebounding World: My Answer Came Too Soon. 4 Comments By Arnold Goodman, M.D.. Published: Feb 12, 2013 10:56 am. In the column I wrote two months ago, I relayed how I was doing 100 days after my allogeneic (donor) stem cell transplant. |
|
Woman honored for work promoting organ donation
Chicago Tribune But a Naperville mother turned around her anguish to start a charitable foundation that affirms life through organ donation. Jill Zuleg’s 16-year-old son, Kyle, died in a freak accident on a family camping trip in October 2010 when a 1-ton tree branch … |
SQNM, LIFE and ILMN Rated by Street-Wire as Biotech Companies See …SmallCap NetworkOn Monday, Life Technologies announced the receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore HLA typing …
 International Business Times |
New Zealand Coroner: Woman’s Addiction to Coca-Cola Binging Caused Her …
International Business Times A coroner in New Zealand concluded that a 31-year-old woman from the southern town of Glengarry died from heart failure, largely because she drank up to 2.6 gallons (10 liters) of Coca-Cola per day. That’s equivalent to about 2.2 pounds of raw sugar … Coke consumption major factor in death, Coroner rules3News NZ |
PRN Physician Recommended Nutriceuticals Announces the Launch of an …Canada NewsWire (press release)He is an expert in stem cell transplantation, tissue engineering, corneal procedures, LASIK and other refractive surgery techniques, and has also inve…
Weekend cyclosporine A therapy comparable to daily treatment for psoriasisHealioA 2-day weekend regimen and a continuous regimen of cyclosporine A for 20 weeks showed comparable results as treatment for plaque psoriasis, according to data from a recent…
|
Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System …
PR Newswire (press release) 12, 2013 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for the Promus PREMIER™ Everolimus-Eluting Platinum Chromium Coronary Stent System, the company’s next-generation durable polymer drug-eluting … |
Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Stent System …MarketWatch (press release)It is the only platform to feature a customized Platinum Chromium (PtCr) stent architecture, the market-leading Everolimus drug coating and fluorinated c…
Honors & Other ThingsUPENN AlmanacDr. June received the prize along with Dr. Bruce R. Blazar of the University of Minnesota for their significant advances in the field of bone marrow transplantation (BMT) and adoptive immunotherapy. The Ernest Beut…
Forbes IndiaStem Cells Industry: The Battle WithinForbes IndiaFor seven years, the startup, promoted by the Manipal Group and led by chief executive BN Manohar, has been at the bench studying stem cells in its labs in India and Malaysia. With a series …